Changchun BCHT Biotechnology Co.

Multiple major Chinese vaccine manufacturers are expecting annual profits to have slumped in 2024, as fiercer competition, destocking at vaccination clinics and a slowing Chinese economy all weigh on

China’s first homegrown vaccine for herpes zoster (shingles), Ganwei, developed by Changchun BCHT Biotechnology Co. (BCHT), had a strong commercial launch in 2023, setting the stage for a showdown w

In China, speed matters. A fast launch and quick roll-out of a new drug or vaccine to patients who need it can sometimes make or break a product. In an eye-popping, three-year purchasing deal worth up

IN VITRO DIAGNOSTICS Alliances Abbott Laboratories Inc. Idera Pharmaceuticals Inc. Idera Pharmaceuticals Inc. (toll-like receptor (TLR) antagonists for autoimmune diseases and B-cell lymphomas) si